Companies QuidelOrtho Corp
QuidelOrtho (QDEL): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me QuidelOrtho Corp’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers74th pct.Of 19 peer CEOs
CEO pay, last three years
- $15,044,937FY2024
- $11,255,782FY2025
CEO total pay was $11,255,782 in fiscal 2025, down from $15,044,937 in fiscal 2024.
FY2025: salary $1,000,000 · bonus $0 · stock awards $8,965,822 · option awards $0
Executives and directors
Brian Blaser · CEOPhilip McLellan · COOJonathan Siegrist · CTOJoseph Busky · CFOMichelle Hodges · General CounselAnn D. Rhoads · Independent DirectorEdward L. Michael · Independent DirectorEvelyn S. Dilsaver · Independent DirectorJohn R. Chiminski · Independent DirectorJoseph D. Wilkins Jr · Independent DirectorKenneth F. Buechler, Ph.D · Chair of the BoardKenneth J. Widder, M.D · Independent DirectorMary Lake Polan, M.D., Ph.D., M.P.H · Independent DirectorMatthew W. Strobeck, Ph.D · Independent DirectorR. Scott Huennekens · Independent Director
Frequently asked questions
Who was the highest-paid executive at QuidelOrtho Corp in fiscal 2025?
As disclosed, Brian Blaser (President and Chief Executive Officer) was the highest-paid executive at QuidelOrtho Corp in fiscal 2025, with total compensation of $11,255,782.
How does QuidelOrtho Corp's chief executive pay compare to its disclosed peer group?
As disclosed, Brian Blaser's total compensation ranked at the 74th percentile of QuidelOrtho Corp's disclosed peer group.
What is QuidelOrtho Corp's CEO-to-median employee pay ratio?
As disclosed, QuidelOrtho Corp's CEO-to-median employee pay ratio was 154:1.
How did shareholders vote on QuidelOrtho Corp's executive compensation?
As disclosed, 97.36% of shareholders supported QuidelOrtho Corp's executive compensation in the latest say-on-pay vote.
How much does QuidelOrtho Corp spend in total on board compensation for fiscal 2025?
As disclosed, QuidelOrtho Corp reported total board compensation of $3,175,098 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Brian Blaser | $1,000,000 | $0 | $8,965,822 | $0 | $1,274,500 | $0 | $15,460 | $11,255,782 |
| President and Chief Executive Officer | ||||||||
| Joseph Busky | 680,000 | 1,150,999 | 2,714,831 | 0 | 795,328 | 0 | 14,462 | 5,355,620 |
| Chief Financial Officer | ||||||||
| Michelle Hodges | 625,000 | 533,025 | 1,121,526 | 575,702 | 637,250 | 0 | 15,567 | 3,508,070 |
| Former Chief Legal Officer | ||||||||
| Philip McLellan | 515,000 | 100,000 | 639,439 | 359,801 | 393,821 | 0 | 13,931 | 2,021,992 |
| Chief Operations Officer | ||||||||
| Jonathan Siegrist | 575,000 | 250,000 | 319,698 | 179,925 | 452,640 | 0 | 13,833 | 1,791,096 |
| Executive Vice President of R&D and Chief Technology Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Brian Blaser | $11,255,782 | $15,044,937 | — | ↓ −3,789,155 |
| Joseph Busky | 5,355,620 | 4,699,610 | 2,943,018 | ↑ +656,010 |
| Michelle Hodges | 3,508,070 | 3,311,100 | 1,800,485 | ↑ +196,970 |
| Philip McLellan | 2,021,992 | 1,622,222 | — | ↑ +399,770 |
| Jonathan Siegrist | 1,791,096 | 2,724,630 | — | ↓ −933,534 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The core objectives of our compensation program continue to be to (1) support our mission, strategic imperatives and values by adopting a pay-for-performance philosophy that provides incentives to our executive officers and employees that are designed to support this core objective; (2) create stockholder value and align the interests of management with those of our stockholders; and (3) attract, retain and motivate highly qualified and experienced executives.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Jonathan Siegrist | OPTION | 2025-01-29 | — | — | 7,347 | — | $179,925 |
| Joseph Busky | PSU | 2025-01-29 | 12,638 | 25,275 | — | 50,550 | 1,614,820 |
| Brian Blaser | PSU | 2025-01-29 | 48,254 | 96,507 | — | 193,014 | 6,165,832 |
| Michelle Hodges | RSU | 2025-01-29 | — | — | 23,509 | — | 1,023,112 |
| Michelle Hodges | OPTION | 2025-01-29 | — | — | 23,508 | — | 575,702 |
| Philip McLellan | OPTION | 2025-01-29 | — | — | 14,692 | — | 359,801 |
| Michelle Hodges | RSU | 2025-04-18 | — | — | 3,910 | — | 98,415 |
| Jonathan Siegrist | RSU | 2025-01-29 | — | — | 7,346 | — | 319,698 |
| Brian Blaser | RSU | 2025-01-29 | — | — | 64,338 | — | 2,799,990 |
| Philip McLellan | RSU | 2025-01-29 | — | — | 14,693 | — | 639,439 |
| Joseph Busky | RSU | 2025-01-29 | — | — | 25,276 | — | 1,100,012 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Jonathan Siegrist | $319,698 | $0 | $179,925 | 0.0% |
| Joseph Busky | 1,100,012 | 1,614,820 | 0 | 59.5% |
| Brian Blaser | 2,799,990 | 6,165,832 | 0 | 68.8% |
| Michelle Hodges | 1,121,527 | 0 | 575,702 | 0.0% |
| Philip McLellan | 639,439 | 0 | 359,801 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Philip McLellan | RSU | 847 | — | $24,817 |
| Philip McLellan | RSU | 1,127 | — | 33,021 |
| Philip McLellan | Option | 1,127 | 103.36 | — |
| Michelle Hodges | RSU | 1,610 | — | 47,173 |
| Michelle Hodges | Option | 1,610 | 103.36 | — |
| Michelle Hodges | RSU | 1,814 | — | 53,150 |
| Philip McLellan | RSU | 1,946 | — | 57,018 |
| Philip McLellan | Option | 1,946 | 88.67 | — |
| Michelle Hodges | Option | 2,462 | 87.46 | — |
| Michelle Hodges | RSU | 2,463 | — | 72,166 |
| Michelle Hodges | RSU | 3,910 | — | 114,563 |
| Joseph Busky | RSU | 4,925 | — | 144,303 |
| Joseph Busky | Option | 4,925 | 87.46 | — |
| Michelle Hodges | RSU | 6,396 | — | 187,403 |
| Michelle Hodges | Option | 6,396 | 67.02 | — |
| Philip McLellan | RSU | 6,476 | — | 189,747 |
| Philip McLellan | Option | 6,476 | 39.08 | — |
| Jonathan Siegrist | RSU | 7,346 | — | 215,238 |
| Jonathan Siegrist | Option | 7,347 | 43.52 | — |
| Michelle Hodges | RSU | 10,698 | — | 313,451 |
| Joseph Busky | RSU | 11,936 | — | 349,725 |
| Joseph Busky | RSU | 11,937 | — | 349,754 |
| Philip McLellan | Option | 14,692 | 43.52 | — |
| Philip McLellan | RSU | 14,693 | — | 430,505 |
| Michelle Hodges | Option | 23,508 | 43.52 | — |
| Michelle Hodges | RSU | 23,509 | — | 688,814 |
| Joseph Busky | RSU | 25,275 | — | 740,558 |
| Joseph Busky | RSU | 25,276 | — | 740,587 |
| Jonathan Siegrist | RSU | 37,314 | — | 1,093,300 |
| Brian Blaser | RSU | 41,518 | — | 1,216,477 |
| Brian Blaser | RSU | 64,338 | — | 1,885,103 |
| Brian Blaser | PSU | 66,725 | — | 1,955,043 |
| Brian Blaser | RSU | 93,416 | — | 2,737,089 |
| Brian Blaser | RSU | 96,507 | — | 2,827,655 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Kenneth F. Buechler, Ph.DIndependent · Board Chair · Compensation (Chair) · Science and Technology | $165,000 | $259,477 | $0 | $0 | $0 | $424,477 |
| Kenneth J. Widder, M.DIndependent · Compensation · Nominating and Governance · Science and Technology (Chair) | 90,000 | 236,999 | 0 | 0 | 0 | 326,999 |
| Edward L. MichaelIndependent · Audit (Chair) · Science and Technology | 95,000 | 228,973 | 0 | 0 | 0 | 323,973 |
| Ann D. RhoadsIndependent · Compensation · Nominating and Governance (Chair) | 100,000 | 219,994 | 0 | 0 | 0 | 319,994 |
| John R. ChiminskiIndependent · Audit · Nominating and Governance | 91,101 | 224,975 | 0 | 0 | 0 | 316,076 |
| Mary Lake Polan, M.D., Ph.D., M.P.HIndependent · Compensation · Nominating and Governance | 75,000 | 232,478 | 0 | 0 | 0 | 307,478 |
| R. Scott HuennekensIndependent · Audit · Nominating and Governance | 91,101 | 210,000 | 0 | 0 | 0 | 301,101 |
| Evelyn S. DilsaverIndependent · Audit · Compensation | 75,000 | 210,000 | 0 | 0 | 0 | 285,000 |
| Joseph D. Wilkins JrIndependent · Audit · Nominating and Governance | 75,000 | 210,000 | 0 | 0 | 0 | 285,000 |
| Matthew W. Strobeck, Ph.DIndependent · Audit · Science and Technology · Not standing for re-election | 75,000 | 210,000 | 0 | 0 | 0 | 285,000 |
| Brian J. BlaserEmployee director | 0 | 0 | 0 | — | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $75,000 |
|---|---|
| Annual equity retainer | $210,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $932,202 |
| Equity awards (grant-date value) | $2,242,896 |
| All other compensation | $0 |
| Total cost of the board | $3,175,098 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names QuidelOrtho as a peer
Companies that benchmark against QDEL
19 companies name QDEL as a compensation peer
- BIO-RAD LABORATORIES, INC.BIOFY2025
- BIO-TECHNE CorpTECHFY2025
- DENTSPLY SIRONA Inc.XRAYFY2025
- Elanco Animal Health IncELANFY2025
- EXACT SCIENCES CORPEXASFY2024
- Fortrea Holdings Inc.FTREFY2025
- GLOBUS MEDICAL INCGMEDFY2025
- HAEMONETICS CORPHAEFY2026
- INTEGRA LIFESCIENCES HOLDINGS CORPIARTFY2025
- MASIMO CORPMASIFY2025
- MERIT MEDICAL SYSTEMS INCMMSIFY2025
- NEOGEN CORPNEOGFY2026
- NEOGENOMICS INCNEOFY2025
- NOVANTA INCNOVTFY2025
- Penumbra IncPENFY2025
- Progyny, Inc.PGNYFY2025
- REVVITY, INC.RVTYFY2025
- Sotera Health CoSHCFY2025
- TANDEM DIABETES CARE INCTNDMFY2025
Each company listed discloses QDEL in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named QDEL in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
ENOV Enovis CorporationEVH Evolent Health, Inc.EXAS Exact Sciences CorporationFTRE Fortrea Holdings Inc.IART Integra LifeSciences Holdings CorporationMASI Masimo CorporationOMCL Omnicell, Inc.TDOC Teladoc Health, Inc.SHC Sotera Health CompanyRDNT RadNet, Inc.TFX Teleflex Inc.MDRX Veradigm Inc.CNMD CONMED CorporationNVST Envista Holdings CorporationBRKR Bruker CorporationICUI ICU Medical, Inc.BIO Bio-Rad Laboratories, Inc.ITGR Integer Holdings CorporationXRAY Dentsply Sirona Inc.
Peer reciprocity
The companies QuidelOrtho Corp names as compensation peers that name it back in their own disclosed peer groups.
Exact Sciences Corporation (EXAS)132Fortrea Holdings Inc. (FTRE)133Integra LifeSciences Holdings Corporation (IART)134Masimo Corporation (MASI)135Sotera Health Company (SHC)136Dentsply Sirona Inc. (XRAY)137
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Masimo Corporation | 2025 | Catherine Szyman | $850,048 | $16,388,693 | $1,399,998 | $1,130,000 | $19,797,140 |
| 2 | Exact Sciences Corporation | 2024 | Kevin Conroy | 1,083,368 | 13,496,138 | 0 | 712,329 | 15,539,378 |
| 3 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 4 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 5 | Fortrea Holdings Inc. | 2025 | Anshul Thakral | 401,923 | 10,479,169 | 0 | 687,500 | 11,584,483 |
| 6 | QuidelOrtho Corp | 2025 | Brian Blaser | 1,000,000 | 8,965,822 | 0 | 1,274,500 | 11,255,782 |
| 7 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 8 | Sotera Health Company | 2025 | Michael Petras | 1,130,699 | 8,022,400 | 0 | 1,484,890 | 10,656,063 |
| 9 | Envista Holdings Corporation | 2025 | Paul Keel | 1,100,000 | 5,440,152 | 1,360,045 | 2,486,550 | 10,559,567 |
| 10 | Integra LifeSciences Holdings Corporation | 2025 | Mojdeh Poul | 1,009,616 | 5,219,868 | 2,250,011 | 174,563 | 9,375,551 |
| 11 | Enovis Corporation | 2025 | Damien McDonald | 634,615 | 7,262,644 | 0 | 812,749 | 9,242,161 |
| 12 | Dentsply Sirona Inc. | 2025 | Daniel Scavilla | 431,753 | 3,484,488 | 3,221,523 | 437,150 | 8,760,139 |
| 13 | Integer Holdings Corporation | 2025 | Joseph Dziedzic | 1,235,000 | 5,999,951 | 0 | 1,323,766 | 8,671,332 |
| 14 | Bio-Rad Laboratories, Inc. | 2025 | Norman Schwartz | 1,089,877 | 4,856,574 | 1,458,975 | 562,088 | 7,995,841 |
| 15 | Conmed Corporation | 2025 | Patrick Beyer | 891,100 | 2,499,971 | 2,499,977 | 1,129,469 | 7,634,873 |
| 16 | Omnicell, Inc. | 2025 | Randall Lipps | 846,891 | 5,219,576 | 0 | 1,411,485 | 7,531,852 |
| 17 | Teleflex Inc. | 2025 | Liam Kelly | 1,144,400 | 2,005,604 | 2,886,518 | 227,280 | 6,732,419 |
| 18 | ICU Medical, Inc. | 2025 | Vivek Jain | 775,000 | 4,500,023 | 0 | 1,162,500 | 6,452,042 |
| 19 | Veradigm Inc. | 2024 | Tom Langan | 608,333 | 5,221,699 | 0 | 452,926 | 6,297,358 |
| 20 | Bruker Corporation | 2025 | Frank Laukien | 976,554 | 1,623,407 | 1,488,109 | 587,270 | 4,706,388 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| QuidelOrtho Corp | not disclosed | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) | Compensia |
| Bio-Rad Laboratories, Inc. | not disclosed | not disclosed | not disclosed | Compensia, Inc. |
| Bruker Corporation | 43.0% | RSU 52 · Options 48 | not disclosed | Aon's Human Capital Solutions Practice |
| Conmed Corporation | 126.8% | Options 50 · PSU 50 | Yes — rTSR | Compensia, Inc. |
| Dentsply Sirona Inc. | 66% | PSU 50 · Options 50 | No | Frederic W. Cook & Co., Inc. |
| Enovis Corporation | 92.2% | PSU 50 · RSU 50 | Yes — Relative TSR vs. S&P 500 Health Care Equipment Select Industry Index | FW Cook |
| Envista Holdings Corporation | 151% | PSU 60 · Options 20 · RSU 20 | No | Frederic W. Cook & Co, Inc. |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| Exact Sciences Corporation | 47% | PSU 60 · RSU 40 | No | Aon |
| Fortrea Holdings Inc. | 68.5% | PSU 50 · RSU 50 | No | Pay Governance LLC |
| ICU Medical, Inc. | 150% | PSU 50 · RSU 50 | No | Compensia |
| Integer Holdings Corporation | 85.75% | PSU 66 · RSU 34 | Yes — Relative TSR versus peer group | FW Cook |
| Integra LifeSciences Holdings Corporation | 40% | PSU 50 · Options 25 · RSU 25 | No | WTW |
| Masimo Corporation | not disclosed | not disclosed | not disclosed | FW Cook |
| Omnicell, Inc. | 133.3% | RSU 50 · PSU 50 | No | Exequity |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Sotera Health Company | 103% | PSU 40 · RSU 40 · Other 20 | No | Exequity, LLP |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
| Teleflex Inc. | 25.9% | Options 55 · RSU 25 · PSU 20 | Yes — Absolute TSR | FW Cook |
| Veradigm Inc. | not disclosed | RSU 50 · PSU 50 | not disclosed | Compensia |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-16 | 55,716,067 | 1,486,910 | 22,228 | 97.36% | Passed |
| 2025 | 2025-05-20 | 53,564,697 | 5,878,744 | 17,357 | 90.08% | Passed |
| 2024 | 2024-05-14 | 54,888,387 | 3,194,023 | 879,159 | 93.09% | Passed |
| 2023 | 2023-05-16 | 50,220,763 | 9,027,108 | 75,428 | 84.76% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-16 | 97.36%a |
| 2025 | 2025-05-20 | 90.08%b |
| 2024 | 2024-05-14 | 93.09%c |
a. Approved under the standard stated in the filing — “broker non-votes (if any) will have no effect on the outcome of the proposals, while abstentions will have the same effect as a vote "AGAINST" the proposals.”.
b. Approved under the standard stated in the filing — “broker non-votes (if any) will have no effect on the outcome of the proposals, while abstentions will have the same effect as a vote "AGAINST" the proposals.”.
c. Approved under the standard stated in the filing — “broker non-votes (if any) will have no effect on the outcome of the proposals, while abstentions will have the same effect as a vote "AGAINST" the proposals.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 154 : 1 |
|---|---|
| CEO total compensation | $11,255,782 |
| Median employee compensation | $73,316 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Brian J. Blaser | President and CEO | 2026-05-15 | A | 20,759 | $0 | $0 | Common | Form 4 ↗ |
| Brian J. Blaser | President and CEO | 2026-05-15 | D | 20,759 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brian J. Blaser | President and CEO | 2026-05-15 | D | 10,252 | 10 | 105,801 | Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-22 | A | 1,173 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-05-22 | — | 1,407 | — | — | 1 insider, 2 accrual rows | ||
| Ann D. Rhoads | Director | 2026-05-22 | A | 234 | 0 | 0 | Common | Form 4 ↗ |
| R. Scott Huennekens | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Matthew Strobeck | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Matthew Strobeck | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Evelyn S. Dilsaver | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph D. Wilkins Jr | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Evelyn S. Dilsaver | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Scott Huennekens | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Joseph D. Wilkins Jr | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-06 | — | 5,564 | — | — | 4 insiders, 8 accrual rows | ||
| POLAN MARY LAKE PH D | Director | 2026-06-06 | A | 749 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-06 | A | 273 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-06 | A | 289 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-06 | A | 497 | 0 | 0 | Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-06 | A | 224 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-06 | A | 1,659 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-06 | A | 963 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-06 | A | 910 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-25 | A | 12,204 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-25 | A | 3,661 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-06-25 | — | 6,192 | — | — | 5 insiders, 5 accrual rows | ||
| Kenneth J. Widder | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Evelyn S. Dilsaver | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-06-25 | A | 3,698 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-25 | A | 5,547 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-06-25 | A | 5,547 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph D. Wilkins Jr | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Scott Huennekens | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-25 | A | 6,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-25 | A | 3,513 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-07-01 | D | 5,797 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-07-01 | D | 2,096 | 18 | 38,105 | Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-07-01 | A | 5,797 | 0 | 0 | Common | Form 4 ↗ |
| Micah W. Young | Chief Financial Officer | 2026-07-15 | A | 356,555 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-08-15 | D | 162 | 14 | 2,317 | Common | Form 4 ↗ |
| Dividend-equivalent accruals | 2026-08-15 | — | 446 | — | — | 1 insider, 1 accrual row | ||
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-08-15 | A | 446 | 0 | 0 | Common | Form 4 ↗ |
| Ronald Lee Bowman | Chief Human Resources Officer | 2026-09-15 | D | 921 | 11 | 9,790 | Common | Form 4 ↗ |
| Ronald Lee Bowman | Chief Human Resources Officer | 2026-09-15 | A | 2,566 | 0 | 0 | Common | Form 4 ↗ |
| Ronald Lee Bowman | Chief Human Resources Officer | 2026-09-15 | D | 2,566 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jonathan Siegrist | EVP of R&D & CTO | 2026-10-15 | D | 18,657 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jonathan Siegrist | EVP of R&D & CTO | 2026-10-15 | D | 6,695 | 14 | 93,127 | Common | Form 4 ↗ |
| Jonathan Siegrist | EVP of R&D & CTO | 2026-10-15 | A | 18,657 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
View all 77 transactions
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Brian J. Blaser | President and CEO | 2026-05-15 | A | 20,759 | $0 | $0 | Common | Form 4 ↗ |
| Brian J. Blaser | President and CEO | 2026-05-15 | D | 20,759 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Brian J. Blaser | President and CEO | 2026-05-15 | D | 10,252 | 10 | 105,801 | Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-22 | A | 1,173 | 0 | 0 | Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-22 | D | 234 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-22 | D | 1,173 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-22 | A | 234 | 0 | 0 | Common | Form 4 ↗ |
| R. Scott Huennekens | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Matthew Strobeck | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Matthew Strobeck | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Evelyn S. Dilsaver | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph D. Wilkins Jr | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Evelyn S. Dilsaver | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-05-29 | D | 6,829 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Scott Huennekens | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Joseph D. Wilkins Jr | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-05-29 | A | 6,829 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-06 | D | 289 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-06 | D | 963 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-06 | D | 497 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-06 | D | 224 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-06 | A | 749 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-06 | D | 273 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-06 | D | 1,659 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-06 | D | 749 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-06 | D | 910 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-06 | A | 273 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-06 | A | 289 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-06 | A | 497 | 0 | 0 | Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-06 | A | 224 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-06 | A | 1,659 | 0 | 0 | Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-06 | A | 963 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-06 | A | 910 | 0 | 0 | Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-25 | A | 12,204 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-25 | A | 3,661 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-06-25 | A | 369 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Evelyn S. Dilsaver | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-06-25 | A | 3,698 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-25 | A | 5,547 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-06-25 | A | 5,547 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-25 | A | 1,053 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-25 | A | 1,664 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| POLAN MARY LAKE PH D | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Ann D. Rhoads | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Joseph D. Wilkins Jr | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| R. Scott Huennekens | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-25 | A | 1,997 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth F. Buechler | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-06-25 | A | 1,109 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Kenneth J. Widder | Director | 2026-06-25 | A | 6,656 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Edward L. Michael | Director | 2026-06-25 | A | 3,513 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| John R. Chiminski | Director | 2026-06-25 | A | 15,532 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-07-01 | D | 5,797 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-07-01 | D | 2,096 | 18 | 38,105 | Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-07-01 | A | 5,797 | 0 | 0 | Common | Form 4 ↗ |
| Micah W. Young | Chief Financial Officer | 2026-07-15 | A | 356,555 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-08-15 | D | 162 | 14 | 2,317 | Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-08-15 | D | 446 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Bryan Michael Hanson | EVP Global Port. Mgmt & Mkting | 2026-08-15 | A | 446 | 0 | 0 | Common | Form 4 ↗ |
| Ronald Lee Bowman | Chief Human Resources Officer | 2026-09-15 | D | 921 | 11 | 9,790 | Common | Form 4 ↗ |
| Ronald Lee Bowman | Chief Human Resources Officer | 2026-09-15 | A | 2,566 | 0 | 0 | Common | Form 4 ↗ |
| Ronald Lee Bowman | Chief Human Resources Officer | 2026-09-15 | D | 2,566 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jonathan Siegrist | EVP of R&D & CTO | 2026-10-15 | D | 18,657 | 0 | 0 | Derivative, Class A Common | Form 4 ↗ |
| Jonathan Siegrist | EVP of R&D & CTO | 2026-10-15 | D | 6,695 | 14 | 93,127 | Common | Form 4 ↗ |
| Jonathan Siegrist | EVP of R&D & CTO | 2026-10-15 | A | 18,657 | 0 | 0 | Common | Form 4 ↗ |
Sources (137 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Brian Blaser. DEF 14A, filed 2026-04-27. Section “Summary Compensation Table” · page 55. As printed: 11,255,782. View filing ↗
- Section 01, Joseph Busky. DEF 14A, filed 2026-04-27. Section “Summary Compensation Table” · page 55. As printed: 5,355,620. View filing ↗
- Section 01, Michelle Hodges. DEF 14A, filed 2026-04-27. Section “Summary Compensation Table” · page 55. As printed: 3,508,070. View filing ↗
- Section 01, Philip McLellan. DEF 14A, filed 2026-04-27. Section “Summary Compensation Table” · page 55. As printed: 2,021,992. View filing ↗
- Section 01, Jonathan Siegrist. DEF 14A, filed 2026-04-27. Section “Summary Compensation Table” · page 55. As printed: 1,791,096. View filing ↗
- Section 03, Jonathan Siegrist OPTION. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Joseph Busky PSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Blaser PSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Michelle Hodges RSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Michelle Hodges OPTION. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Philip McLellan OPTION. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Michelle Hodges RSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Jonathan Siegrist RSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Brian Blaser RSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Philip McLellan RSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Joseph Busky RSU. DEF 14A, filed 2026-04-27. Section “Grants of Plan-Based Awards in Fiscal Year 2025” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-27. Section “CEO Pay Ratio”. As printed: 154 : 1. View filing ↗
- Section 08, Kenneth F. Buechler, Ph.D. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 424,477. View filing ↗
- Section 08, Kenneth J. Widder, M.D. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 326,999. View filing ↗
- Section 08, Edward L. Michael. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 323,973. View filing ↗
- Section 08, Ann D. Rhoads. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 319,994. View filing ↗
- Section 08, John R. Chiminski. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 316,076. View filing ↗
- Section 08, Mary Lake Polan, M.D., Ph.D., M.P.H. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 307,478. View filing ↗
- Section 08, R. Scott Huennekens. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 301,101. View filing ↗
- Section 08, Evelyn S. Dilsaver. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 285,000. View filing ↗
- Section 08, Joseph D. Wilkins Jr. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 285,000. View filing ↗
- Section 08, Matthew W. Strobeck, Ph.D. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 285,000. View filing ↗
- Section 08, Brian J. Blaser. DEF 14A, filed 2026-04-27. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Brian J. Blaser 2026-05-15. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brian J. Blaser 2026-05-15. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Brian J. Blaser 2026-05-15. Form 4, filed 2026-05-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-05-22. Form 4, filed 2026-05-27. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Scott Huennekens 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Chiminski 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Strobeck 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Matthew Strobeck 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Evelyn S. Dilsaver 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph D. Wilkins Jr 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Evelyn S. Dilsaver 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Scott Huennekens 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph D. Wilkins Jr 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Chiminski 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-05-29. Form 4, filed 2026-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-06. Form 4, filed 2026-06-09. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Evelyn S. Dilsaver 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Chiminski 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, POLAN MARY LAKE PH D 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ann D. Rhoads 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Joseph D. Wilkins Jr 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, R. Scott Huennekens 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth F. Buechler 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Chiminski 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Kenneth J. Widder 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Edward L. Michael 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John R. Chiminski 2026-06-25. Form 4, filed 2026-06-29. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Michael Hanson 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Michael Hanson 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Michael Hanson 2026-07-01. Form 4, filed 2026-07-02. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Micah W. Young 2026-07-15. Form 4, filed 2026-07-16. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Michael Hanson 2026-08-15. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Michael Hanson 2026-08-15. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Bryan Michael Hanson 2026-08-15. Form 4, filed 2026-08-18. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald Lee Bowman 2026-09-15. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald Lee Bowman 2026-09-15. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Ronald Lee Bowman 2026-09-15. Form 4, filed 2026-09-17. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jonathan Siegrist 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jonathan Siegrist 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Jonathan Siegrist 2026-10-15. Form 4, filed 2026-10-19. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-16. Item 5.07 · say-on-pay result. As reported: 97.36% (votes for as printed: 55,716,067). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-05-27. Item 5.07 · say-on-pay result. As reported: 90.08% (votes for as printed: 53,564,697). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-05-17. Item 5.07 · say-on-pay result. As reported: 93.09% (votes for as printed: 54,888,387). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 932,202 + equity 2,242,896 + all other 0 = 3,175,098, summed across the director compensation table rows.
- Masimo Corporation, Section 10b CEO total. 10-K/A, filed 2026-05-01. CEO total compensation as printed in Masimo Corporation's own proxy. As printed: 19,797,140. View filing ↗
- Exact Sciences Corporation, Section 10b CEO total. DEF 14A, filed 2025-04-29. CEO total compensation as printed in Exact Sciences Corporation's own proxy. As printed: 15,539,378. View filing ↗
- Evolent Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. View filing ↗
- RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
- Fortrea Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in Fortrea Holdings Inc.'s own proxy. As printed: 11,584,483. View filing ↗
- QuidelOrtho Corp (subject), Section 10b CEO total. DEF 14A, filed 2026-04-27. CEO total compensation as printed in QuidelOrtho Corp's own proxy. As printed: 11,255,782. View filing ↗
- Teladoc Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. View filing ↗
- Sotera Health Company, Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Sotera Health Company's own proxy. As printed: 10,656,063. View filing ↗
- Envista Holdings Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Envista Holdings Corporation's own proxy. As printed: 10,559,567. View filing ↗
- Integra LifeSciences Holdings Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Integra LifeSciences Holdings Corporation's own proxy. As printed: 9,375,551. View filing ↗
- Enovis Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Enovis Corporation's own proxy. As printed: 9,242,161. View filing ↗
- Dentsply Sirona Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Dentsply Sirona Inc.'s own proxy. As printed: 8,760,139. View filing ↗
- Integer Holdings Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Integer Holdings Corporation's own proxy. As printed: 8,671,332. View filing ↗
- Bio-Rad Laboratories, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-25. CEO total compensation as printed in Bio-Rad Laboratories, Inc.'s own proxy. As printed: 7,995,841. View filing ↗
- Conmed Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Conmed Corporation's own proxy. As printed: 7,634,873. View filing ↗
- Omnicell, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Omnicell, Inc.'s own proxy. As printed: 7,531,852. View filing ↗
- Teleflex Inc., Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Teleflex Inc.'s own proxy. As printed: 6,732,419. View filing ↗
- ICU Medical, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in ICU Medical, Inc.'s own proxy. As printed: 6,452,042. View filing ↗
- Veradigm Inc., Section 10b CEO total. DEF 14A, filed 2026-05-26. CEO total compensation as printed in Veradigm Inc.'s own proxy. As printed: 6,297,358. View filing ↗
- Bruker Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Bruker Corporation's own proxy. As printed: 4,706,388. View filing ↗
- Section 10a, Exact Sciences Corporation reciprocity. DEF 14A. Exact Sciences Corporation names QuidelOrtho Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Fortrea Holdings Inc. reciprocity. DEF 14A. Fortrea Holdings Inc. names QuidelOrtho Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Integra LifeSciences Holdings Corporation reciprocity. DEF 14A. Integra LifeSciences Holdings Corporation names QuidelOrtho Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Masimo Corporation reciprocity. DEF 14A. Masimo Corporation names QuidelOrtho Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Sotera Health Company reciprocity. DEF 14A. Sotera Health Company names QuidelOrtho Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Dentsply Sirona Inc. reciprocity. DEF 14A. Dentsply Sirona Inc. names QuidelOrtho Corp in its own disclosed peer group (read from its most recent proxy). View filing ↗